PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Spartan 3, Mod GRF 1-29 + GHRP-6
A growth-hormone-secretagogue blend combining Modified GRF 1-29 (a CJC-1295 without DAC GHRH analog) with GHRP-6 to stimulate pulsatile growth hormone release. It is studied for recovery, body composition, and appetite.
Sign in to rate this peptide.
Modified GRF 1-29 is a stabilized growth-hormone-releasing hormone analog that binds the GHRH receptor on pituitary somatotrophs, increasing the amplitude of growth hormone pulses via cAMP/PKA signaling. GHRP-6 is a growth-hormone-releasing peptide that activates the ghrelin/GHS-R1a receptor, triggering a separate intracellular pathway that amplifies GH release and suppresses somatostatin tone, while also stimulating appetite. Used together, the GHRH analog and the GHS act synergistically through their distinct receptors to produce a larger, more physiologic GH pulse than either alone, which in turn raises IGF-1.